These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35183928)

  • 1. Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia.
    Bijl RC; Cornette JMJ; Brewer AN; Zwart IF; Franx A; Tsigas EZ; Koster MPH
    Pregnancy Hypertens; 2022 Jun; 28():44-50. PubMed ID: 35183928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for preconceptional prediction of recurrent early-onset preeclampsia: derivation and internal validation.
    van Kuijk SM; Nijdam ME; Janssen KJ; Sep SJ; Peeters LL; Delahaije DH; Spaanderman M; Bruinse HW; Franx A; Bots ML; Langenveld J; van der Post J; van Rijn BB; Smits L
    Reprod Sci; 2011 Nov; 18(11):1154-9. PubMed ID: 21673281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.
    Tolcher MC; Sangi-Haghpeykar H; Mendez-Figueroa H; Aagaard KM
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100184. PubMed ID: 33345910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of the competing risk model in screening for preeclampsia.
    Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
    Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.
    Tolcher MC; Chu DM; Hollier LM; Mastrobattista JM; Racusin DA; Ramin SM; Sangi-Haghpeykar H; Aagaard KM
    Am J Obstet Gynecol; 2017 Sep; 217(3):365.e1-365.e8. PubMed ID: 28455079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study.
    Zhang J; Han L; Li W; Chen Q; Lei J; Long M; Yang W; Li W; Zeng L; Zeng S
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):304. PubMed ID: 31426761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
    Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
    Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort.
    Chaudhry SH; Taljaard M; MacFarlane AJ; Gaudet LM; Smith GN; Rodger M; Rennicks White R; Walker MC; Wen SW
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):75. PubMed ID: 30782144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Placental Growth Factor for Prediction of Placental Adverse Outcomes in High-Risk Pregnancies.
    Lecarpentier E; Gris JC; Cochery-Nouvellon E; Mercier E; Abbas H; Thadhani R; Karumanchi SA; Haddad B
    Obstet Gynecol; 2019 Dec; 134(6):1326-1332. PubMed ID: 31764746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
    Wright D; Poon LC; Rolnik DL; Syngelaki A; Delgado JL; Vojtassakova D; de Alvarado M; Kapeti E; Rehal A; Pazos A; Carbone IF; Dutemeyer V; Plasencia W; Papantoniou N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Dec; 217(6):685.e1-685.e5. PubMed ID: 28888591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preeclampsia with aspirin.
    Rolnik DL; Nicolaides KH; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1108-S1119. PubMed ID: 32835720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for preeclampsia in low-risk twin pregnancies at early gestation.
    Chen J; Zhao D; Liu Y; Zhou J; Zou G; Zhang Y; Guo M; Duan T; Van Mieghem T; Sun L
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1346-1353. PubMed ID: 32356359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early preterm preeclampsia outcomes by intended mode of delivery.
    Coviello EM; Iqbal SN; Grantz KL; Huang CC; Landy HJ; Reddy UM
    Am J Obstet Gynecol; 2019 Jan; 220(1):100.e1-100.e9. PubMed ID: 30273585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
    Ngwenya S; Jones B; Mwembe D; Nare H; Heazell AEP
    Pregnancy Hypertens; 2021 Mar; 23():18-26. PubMed ID: 33161225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester preeclampsia screening and prediction.
    Chaemsaithong P; Sahota DS; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1071-S1097.e2. PubMed ID: 32682859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.